CD 1530 structure
|
Common Name | CD 1530 | ||
|---|---|---|---|---|
| CAS Number | 107430-66-0 | Molecular Weight | 398.49400 | |
| Density | 1.29g/cm3 | Boiling Point | 610.7ºC at 760 mmHg | |
| Molecular Formula | C27H26O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 337.2ºC | |
Use of CD 1530CD1530 is a selective RARγ agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma[2]. |
| Name | 4-[7-(1-adamantyl)-6-hydroxynaphthalen-2-yl]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | CD1530 is a selective RARγ agonist with an Kd of 150 nM[1]. CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma[2]. |
|---|---|
| Related Catalog | |
| Target |
RARγ:150 nM (Kd) |
| References |
| Density | 1.29g/cm3 |
|---|---|
| Boiling Point | 610.7ºC at 760 mmHg |
| Molecular Formula | C27H26O3 |
| Molecular Weight | 398.49400 |
| Flash Point | 337.2ºC |
| Exact Mass | 398.18800 |
| PSA | 57.53000 |
| LogP | 6.37840 |
| Vapour Pressure | 9.03E-16mmHg at 25°C |
| Index of Refraction | 1.688 |
| cd 1530 |